Prosecution Insights
Last updated: October 26, 2026

Michael T. Holtzclaw, USPTO Patent Examiner

Listed by the USPTO as HOLTZCLAW, MICHAEL T.

Tech Center 3700 • Art Units: 3792 3796

This examiner grants 78% of resolved cases

Analysis

HOLTZCLAW, MICHAEL T. is assigned to Tech Center 3700 and Art Unit 3792. The record includes 250 resolved cases, with a 78.0% allowance rate and a median of 1004 days to allowance. The 15.5% interview lift indicates a higher allowance outcome for cases involving interviews in this dataset.

The listed companies are Biotronik SE & Co. KG, NEC Corporation, and Cilag GmbH International. The listed firms are BUCHANAN INGERSOLL & ROONEY PC, AMPACC Law Group, PLLC, and ARENTFOX SCHIFF LLP. The outcome profile supports using interviews as one component of prosecution strategy, particularly where a discussion can clarify claim scope. The median timing also supports setting expectations for prosecution that may require sustained follow-up.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

78.0%
Allow Rate
+8.0% vs TC avg
288
Total Applications
+15.5%
Interview Lift
1004
Avg Prosecution Days
Based on 250 resolved cases, 2023–2026

Rejection Statute Breakdown

7.3%
§101 Eligibility
20.4%
§102 Novelty
34.7%
§103 Obviousness
29.0%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18229473 COMMUNICATION APPARATUS, COMMUNICATION METHOD, AND NON-TRANSITORY COMPUTER-READABLE STORAGE MEDIUM Final Rejection NEC Corporation
19022795 SURGICAL TOOL END EFFECTORS WITH ALIGNMENT ARMS Non-Final OA Cilag GmbH International
18877072 SIGNAL GENERATOR FOR A NEUROLOGICAL STIMULATION SYSTEM AND METHOD FOR NEUROLOGICAL STIMULATION Non-Final OA BIOTRONIK SE & Co. KG
18841180 INTRACARDIAC MEDICAL DEVICE AND METHOD OF OPERATING SAME Final Rejection BIOTRONIK SE & Co. KG
18834323 ACTIVE ELECTRICAL SYSTEM AND METHOD FOR OPERATING AN ACTIVE ELECTRICAL SYSTEM Non-Final OA BIOTRONIK SE & Co. KG
18713930 IMPLANTABLE MEDICAL DEVICE FOR PROVIDING A DIAGNOSTIC AND/OR THERAPEUTIC CARDIAC FUNCTION WITHIN A PATIENT Final Rejection BIOTRONIK SE & Co. KG
18786916 AI/ML SPINAL CORD STIMULATION SIGNAL CLASSIFICATION FOR THERAPY OPTIMIZATION AND INSIGHT Non-Final OA Medtronic, Inc.
19091931 CARDIAC MAP DIMMING WITH GUI Non-Final OA BIOSENSE WEBSTER (ISRAEL) LTD.
18826930 Cuff For Providing Vagus Nerve Stimulation Final Rejection United States Government As Represented By The Department Of Veterans Affairs
18956246 ELECTRICAL NEUROSTIMULATION SYSTEM Non-Final OA B. Braun Melsungen AG

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Michael T. Holtzclaw's allowance rate?

78.0% of resolved applications examined by Michael T. Holtzclaw were allowed (250 resolved cases), compared with 66.7% across Art Unit 3792 over the last five years.

Does an interview help with examiner Michael T. Holtzclaw?

This examiner's interview lift is +15.5 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Michael T. Holtzclaw take to allow a patent?

Applications allowed by Michael T. Holtzclaw took 1,004 days on average from filing to allowance.

Which art unit does examiner Michael T. Holtzclaw work in?

Michael T. Holtzclaw examines applications in Art Unit 3792 in Tech Center 3700 (Medical Devices & Mechanical Engineering).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month